业界动态国内医卫资讯
健康老龄化补充剂在大型帕金森病试验中失败
Medscape News · 2026-10-27 20:55
摘要
尽管在较小规模的试验中结果令人鼓舞，但烟酰胺核糖苷在一项3期研究中未能减缓早期帕金森病的进展。Medscape医学新闻
English
Healthy Aging Supplement Fails in Large PD Trial
Despite promising results in smaller trials, nicotinamide riboside fails to slow the progression of early Parkinson’s disease in a phase 3 study. Medscape Medical News